← Leaderboards
Lynn A Sleeper
New England Research Institutes, Inc.
$12,494,891
Attributed
$23,169,859
Total exposure
12
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$62,846,407 · 12
FDA$608,916 · 1
By mechanism
U01$40,784,337 · 7
U10$17,308,325 · 1
R33$2,366,065 · 1
R01$2,295,315 · 2
R61$410,558 · 1
R21$290,723 · 1
Top collaborators
- John Nagi Kheir4 shared
- Sharon L Tennstedt3 shared
- James D Wilkinson2 shared
- Christopher Almond1 shared
- Eva Cheung1 shared
- Caroline Ozment1 shared
- Kathleen Ryan1 shared
Most similar at New England Research Institutes, Inc.
Same institution · by research overlap
- Susan Fera Assmann$43,009,166
- Sharon L Tennstedt$66,981,764
- Julie Elaine Miller$32,681,948
- Sonja M McKinlay$19,814,759
- Donald Brambilla$16,592,912
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingCongenital Heart DisorderData ManagementClinical TrialsClinical ResearchSafetyRandomizedResearch DesignProtocols DocumentationArrhythmiaFundingDesignHeartChildhoodChildHeart DiseasesEchocardiographyData AnalysesClinical Trials Data Monitoring CommitteesData Coordinating CenterMedicalCommunicationInflammatoryMonitor
Grant awards (42)
Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR$802,141
R33 · FY2025 · HL
Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR$768,213
R33 · FY2024 · HL
Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR$795,711
R33 · FY2023 · HL
Multicenter Trial of ECMO in Children with Severe Cardiac Failure using the Cardiohelp System$608,916
R01 · FY2023 · FD · contact PI
Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR$410,558
R61 · FY2022 · HL
Racioethnic and Socioeconomic Impact on Outcomes in Pediatric Cardiomyopathy$131,646
R21 · FY2019 · HL · contact PI
Racioethnic and Socioeconomic Impact on Outcomes in Pediatric Cardiomyopathy$159,077
R21 · FY2018 · HL · contact PI
Pediatric Heart network DCC$8,334,847
U10 · FY2012 · HL
Pediatric Heart network DCC$8,923,478
U10 · FY2011 · HL
Pediatric Heart network DCC$50,000
U10 · FY2011 · HL
Pediatric Heart Network: Data Coordinating Center$4,694,484
U01 · FY2010 · HL · contact PI
Pediatric Heart Network: Data Coordinating Center$148,725
U01 · FY2010 · HL · contact PI
Pediatric Heart Network: Data Coordinating Center$5,541,739
U01 · FY2009 · HL · contact PI
Pediatric Heart Network: Data Coordinating Center$4,625
U01 · FY2009 · HL · contact PI
Pediatric Heart Network: Data Coordinating Center$8,398,604
U01 · FY2008 · HL · contact PI
Pediatric Heart Network: Data Coordinating Center$1,581,000
U01 · FY2008 · HL · contact PI
Pediatric Heart Network: Data Coordinating Center$90,000
U01 · FY2008 · HL · contact PI
Pediatric Heart Network: Data Coordinating Center$5,194,408
U01 · FY2007 · HL · contact PI
Pediatric Heart Network: Data Coordinating Center$4,355,509
U01 · FY2006 · HL · contact PI
Pediatric Heart Disease Clinical Research Network - DCC$2,897,999
U01 · FY2005 · HL
ACE in MR$0
U01 · FY2005 · HL
Ventricular Volumes and Varability (VVV)$0
U01 · FY2005 · HL
Single Ventricle Reconstruction (SVR)$0
U01 · FY2005 · HL
Infant Single Ventricle (ISV) Trial$0
U01 · FY2005 · HL
Kawasaki Disease Pulse Steroid Trial$0
U01 · FY2005 · HL
Fontan Cross-Sectional Stdy$0
U01 · FY2005 · HL
Pediatric Heart Disease Clinical Research Network - DCC$2,399,256
U01 · FY2004 · HL
Fontan Cross-Sectional Study$417,500
U01 · FY2004 · HL
SHOCK TRIAL: LONG-TERM SURVIVAL AND STATISTICAL SUPPORT$295,949
R01 · FY2004 · HL
Kawasaki Disease Pulse Steroid Trial$81,373
U01 · FY2004 · HL
ACE in MR$0
U01 · FY2004 · HL
Infant Single Ventricle (ISV) Trial$0
U01 · FY2004 · HL
Pediatric Heart Disease Clinical Research Network - DCC$2,279,531
U01 · FY2003 · HL
SHOCK TRIAL: LONG-TERM SURVIVAL AND STATISTICAL SUPPORT$291,066
R01 · FY2003 · HL
Kawasaki Disease Pulse Steroid Trial$0
U01 · FY2003 · HL
Infant Single Ventricle (ISV) Trial$0
U01 · FY2003 · HL
Fontan Cross-Sectional Study$0
U01 · FY2003 · HL
Pediatric Heart Disease Clinical Research Network - DCC$1,841,234
U01 · FY2002 · HL
SHOCK TRIAL: LONG-TERM SURVIVAL AND STATISTICAL SUPPORT$297,352
R01 · FY2002 · HL
Pediatric Heart Disease Clinical Research Network - DCC$858,350
U01 · FY2001 · HL
SHOCK TRIAL: LONG-TERM SURVIVAL AND STATISTICAL SUPPORT$362,402
R01 · FY2001 · HL
SHOCK TRIAL: LONG-TERM SURVIVAL AND STATISTICAL SUPPORT$439,630
R01 · FY2000 · HL